search
Back to results

Exercise Therapy in Radiation Therapy (EXERT)

Primary Purpose

Metastatic Cancer

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise Therapy
Sponsored by
Milton S. Hershey Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Metastatic Cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Males and females ≥18 years of age
  • Fluent in written and spoken English
  • Must be able to provide and understand informed consent
  • Must have an ECOG PS of ≤ 2
  • Diagnosed with metastatic disease
  • Cancer patients (stage 1-4)
  • Treatment to primary site or metastatic disease
  • Scheduled to receive radiation therapy at Penn State Cancer Institute
  • Absence of absolute contraindications for exercise according to the American Heart Association (see below)
  • Primary attending oncologist approval
  • Receiving treatment as an outpatient

Exclusion Criteria:

  • Receiving radiation therapy at a location other than Penn State Cancer Institute
  • Not fluent in written and spoken English
  • Evidence in the medical record of an absolute contraindication for exercise
  • Performing > 90 minutes/week of physical activity at the time of initial evaluation
  • Cardiac exclusion criteria:

    • Class II, III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system
    • History of acute coronary syndromes (including myocardial infarction and unstable angina), coronary angioplasty or stenting within the past 6 months prior to the start of radiation therapy
    • Uncontrolled arrhythmias; patients with rate controlled atrial fibrillation for >1 month prior to start of radiation therapy may be eligible
    • syncope
    • acute myocarditis, pericarditis, or endocarditis
    • acute pulmonary embolus or pulmonary infarction
    • thrombosis of lower extremities
    • suspected dissecting aneurysm
    • pulmonary edema
    • respiratory failure
    • acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise
    • mental impairment leading to inability to cooperate
  • Pregnant women
  • In-patient receiving radiation therapy for a radiation emergency (e.g. cord compression, SVC syndrome, brain metastases)
  • High risk of fracture or spine instability (Mirels score ≥7, SINS ≥7)
  • Children (the protocol will only include individuals 18 and older)

Sites / Locations

  • Penn State Cancer Institute

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Exercise

Arm Description

The exercise intervention will utilize the "Moving Through Cancer: A Guide to Exercise for Cancer Survivors" framework. A certified cancer exercise physiologist will work through this guide at radiation therapy visits, with at least 1 visit per week, per the study schema. The cancer exercise physiologist will teach participants proper: warm ups, use of equipment, exercise form, modes of activity, intensity of exercise, flexibility exercises, and cool down. The cancer exercise physiologist will tailor the instruction to convey special considerations for exercise based on treatment and cancer type. The patient will perform supervised exercise in the Exercise Medicine Unit under the guidance of the cancer exercise specialist. The exercise done will be educational in nature (i.e. learning about proper walking form, proper intensity for a warmup/cool down, proper techniques for resistance exercises).

Outcomes

Primary Outcome Measures

Acceptability of exercise intervention: (number of patients agreeing to perform RT+ET)/(number approached)
(number of patients agreeing to perform RT+ET)/(number approached)
Feasibility of exercise intervention: (number of patients who completed RT+ET)/(number agreeing to perform RT+ET)
(number of patients who completed RT+ET)/(number agreeing to perform RT+ET)
Incidence of Treatment- Emergent Adverse Events
Safety of exercise intervention: freedom from any Common Terminology Criteria for Adverse Events (CTCAE) grade 3 or higher event

Secondary Outcome Measures

Change in timed up and go
Timed up and go
change in grip strength
Grip strength
change in quality of life measured via the Godin Physical Activity Questionnaire
The Godin Physical Activity Questionnaire asks how much physical activity the participant engages in during a typical 7-day period.
change in quality of life measured via the Barriers to Exercise RM 5-FM survey
The Barriers to Exercise RM 5-FM survey asks participants about barriers to being active. Response options include: very likely; somewhat likely; somewhat unlikely; very unlikely.
change in quality of life measured via the Work Productivity and Activity Impairment Questionnaire
The Work Productivity and Activity Impairment Questionnaire ask about the effect of the participant's health problems on the ability to work and perform regular activities. A variety of question/response styles are included in the survey.
change in quality of life measured via the Scored Patient-Generated Subjective Global Assessment
The Score Patient-Generated Subjective Global Assessment asks about participant nutrition. A variety of question/response styles are included in the survey.
change in quality of life measured via the EORTC questionnaire
The EORTC Quality of life questionnaire asks a variety of questions about their health regarding physical abilities. Response options include: not at all; a little; quite a bit; very much.
change in quality of life measured via the ECHO EXERT survey
The Experience of Care and Health Outcomes (ECHO) Survey asks three questions about participant experience with the exercise intervention. Response options include: not at all; not much; mixed; somewhat; very much so.
change in quality of life measured via the Health Belief Scale
The Health Belief Scale asks questions regarding exercise therapy. Response options include: strongly disagree - strongly agree, where 1 equals strongly disagree and 4 equals strongly agree.

Full Information

First Posted
March 28, 2019
Last Updated
May 3, 2023
Sponsor
Milton S. Hershey Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03905356
Brief Title
Exercise Therapy in Radiation Therapy
Acronym
EXERT
Official Title
Exercise Therapy in Radiation Therapy (EXERT)
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
February 12, 2020 (Actual)
Primary Completion Date
January 26, 2022 (Actual)
Study Completion Date
January 31, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Milton S. Hershey Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate exercise therapy as a method for potentially improving radiation therapy treatment toxicities for metastatic cancer patients receiving radiation therapy.
Detailed Description
Study Objectives and Endpoints: Aim 1. To determine the acceptability, feasibility, and safety of an exercise intervention among cancer patients receiving radiation therapy. The investigators anticipate that >25% of approached patients will consent to the protocol; >33% of eligible radiation therapy patients who consent will perform the exercise prescribed (based on the response rate from EnACT); and <25% of participants will experience a musculoskeletal impairment (without treatment alterations) and <5% will experience a musculoskeletal injury with symptoms lasting ≥ week or requiring medical attention. The investigators' approach will be to include patients receiving definitive RT; excluding patients at high risk for side effects from combination therapy, including fracture or cardiovascular events. Aim 2. To discern the clinical outcomes of patients receiving RT+ET. The hypothesis is that adding ET to RT will improve patient reported outcomes and physical functioning. The investigators' approach will be to use standardized questionnaires and assessment tools: patient reported outcomes will be assessed using Common Terminology Criteria for Adverse Events - Patient Reported Outcomes (CTCAE-PROs), loaded onto tablets that patients use in the clinic. Questions will assess global PROs relevant to the ability to tolerate RT, including fatigue, pain, nausea, vomiting; and disease-site-specific PROs, including genitourinary/sexual symptoms for patients receiving pelvic RT. RT dose alterations will be documented. Scores will be compared pre- vs post- RT. The investigators will also use standardized measures already used in EnACT, including grip strength, 30-second chair stand, timed up-and-go, and 4-stage balance. Scores will be compared pre- vs post- RT.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metastatic Cancer

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
16 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exercise
Arm Type
Experimental
Arm Description
The exercise intervention will utilize the "Moving Through Cancer: A Guide to Exercise for Cancer Survivors" framework. A certified cancer exercise physiologist will work through this guide at radiation therapy visits, with at least 1 visit per week, per the study schema. The cancer exercise physiologist will teach participants proper: warm ups, use of equipment, exercise form, modes of activity, intensity of exercise, flexibility exercises, and cool down. The cancer exercise physiologist will tailor the instruction to convey special considerations for exercise based on treatment and cancer type. The patient will perform supervised exercise in the Exercise Medicine Unit under the guidance of the cancer exercise specialist. The exercise done will be educational in nature (i.e. learning about proper walking form, proper intensity for a warmup/cool down, proper techniques for resistance exercises).
Intervention Type
Behavioral
Intervention Name(s)
Exercise Therapy
Intervention Description
Certified exercise oncology specialists will personalize, prescribe, and guide ET, including twice weekly resistance training and walking, performed at home, with supervision in the Exercise Medicine Unit. The cancer exercise physiologist will teach participants proper warm ups, use of equipment, exercise form, modes of activity, intensity of exercise, flexibility exercises, and cool down. In addition, patients will be instructed to exercise on their own, at home, according to the instructions from the cancer exercise specialist.
Primary Outcome Measure Information:
Title
Acceptability of exercise intervention: (number of patients agreeing to perform RT+ET)/(number approached)
Description
(number of patients agreeing to perform RT+ET)/(number approached)
Time Frame
1 year
Title
Feasibility of exercise intervention: (number of patients who completed RT+ET)/(number agreeing to perform RT+ET)
Description
(number of patients who completed RT+ET)/(number agreeing to perform RT+ET)
Time Frame
1 year
Title
Incidence of Treatment- Emergent Adverse Events
Description
Safety of exercise intervention: freedom from any Common Terminology Criteria for Adverse Events (CTCAE) grade 3 or higher event
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Change in timed up and go
Description
Timed up and go
Time Frame
3 Months
Title
change in grip strength
Description
Grip strength
Time Frame
3 Months
Title
change in quality of life measured via the Godin Physical Activity Questionnaire
Description
The Godin Physical Activity Questionnaire asks how much physical activity the participant engages in during a typical 7-day period.
Time Frame
3 Months
Title
change in quality of life measured via the Barriers to Exercise RM 5-FM survey
Description
The Barriers to Exercise RM 5-FM survey asks participants about barriers to being active. Response options include: very likely; somewhat likely; somewhat unlikely; very unlikely.
Time Frame
3 Months
Title
change in quality of life measured via the Work Productivity and Activity Impairment Questionnaire
Description
The Work Productivity and Activity Impairment Questionnaire ask about the effect of the participant's health problems on the ability to work and perform regular activities. A variety of question/response styles are included in the survey.
Time Frame
3 Months
Title
change in quality of life measured via the Scored Patient-Generated Subjective Global Assessment
Description
The Score Patient-Generated Subjective Global Assessment asks about participant nutrition. A variety of question/response styles are included in the survey.
Time Frame
3 Months
Title
change in quality of life measured via the EORTC questionnaire
Description
The EORTC Quality of life questionnaire asks a variety of questions about their health regarding physical abilities. Response options include: not at all; a little; quite a bit; very much.
Time Frame
3 Months
Title
change in quality of life measured via the ECHO EXERT survey
Description
The Experience of Care and Health Outcomes (ECHO) Survey asks three questions about participant experience with the exercise intervention. Response options include: not at all; not much; mixed; somewhat; very much so.
Time Frame
3 Months
Title
change in quality of life measured via the Health Belief Scale
Description
The Health Belief Scale asks questions regarding exercise therapy. Response options include: strongly disagree - strongly agree, where 1 equals strongly disagree and 4 equals strongly agree.
Time Frame
3 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Males and females ≥18 years of age Fluent in written and spoken English Must be able to provide and understand informed consent Must have an ECOG PS of ≤ 2 Diagnosed with metastatic disease Cancer patients (stage 1-4) Treatment to primary site or metastatic disease Scheduled to receive radiation therapy at Penn State Cancer Institute Absence of absolute contraindications for exercise according to the American Heart Association (see below) Primary attending oncologist approval Receiving treatment as an outpatient Exclusion Criteria: Receiving radiation therapy at a location other than Penn State Cancer Institute Not fluent in written and spoken English Evidence in the medical record of an absolute contraindication for exercise Performing > 90 minutes/week of physical activity at the time of initial evaluation Cardiac exclusion criteria: Class II, III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system History of acute coronary syndromes (including myocardial infarction and unstable angina), coronary angioplasty or stenting within the past 6 months prior to the start of radiation therapy Uncontrolled arrhythmias; patients with rate controlled atrial fibrillation for >1 month prior to start of radiation therapy may be eligible syncope acute myocarditis, pericarditis, or endocarditis acute pulmonary embolus or pulmonary infarction thrombosis of lower extremities suspected dissecting aneurysm pulmonary edema respiratory failure acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise mental impairment leading to inability to cooperate Pregnant women In-patient receiving radiation therapy for a radiation emergency (e.g. cord compression, SVC syndrome, brain metastases) High risk of fracture or spine instability (Mirels score ≥7, SINS ≥7) Children (the protocol will only include individuals 18 and older)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kathleen Sturgeon, PhD
Organizational Affiliation
Penn State College of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Penn State Cancer Institute
City
Hershey
State/Province
Pennsylvania
ZIP/Postal Code
17033
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Exercise Therapy in Radiation Therapy

We'll reach out to this number within 24 hrs